論文の公開元へ

書き出し

Refer/BibIX

RIS

BibTeX

TSV

Early diagnosis of sinusoidal obstruction syndrome after hematopoietic stem cell transplantation, with modified diagnostic criteria including refractory thrombocytopenia

Ichikawa, Hiroya Yakushijin, Kimikazu Miyata, Yoshiharu Kanehira, Hirofumi Joyce, Miki Hirakawa, Yuri Matsumoto, Sakuya Nagao, Shigeki Sakai, Rina Kurata, Keiji Kitao, Akihito Saito, Yasuyuki Kawamoto, Shinichiro Yamamoto, Katsuya Ito, Mitsuhiro Murayama, Tohru Matsuoka, Hiroshi Minami, Hironobu 神戸大学

2023.08

概要

Sinusoidal obstruction syndrome (SOS) is a fatal complication of hematopoietic stem cell transplantation (HSCT). Early diagnosis for SOS can improve clinical outcomes significantly. Here, we performed a retrospective study to investigate the Cairo diagnostic criteria, in which SOS was defined as the development of two or more in seven events, including transfusion-refractory thrombocytopenia. Among 154 cases of allogeneic HSCT, 10 cases of SOS using the European Society for Blood and Marrow Transplantation criteria (EBMT16) as the reference standard were identified. The original Cairo criteria could diagnose SOS 5 days earlier than any other established criteria, with some false-positive results (sensitivity = 100.0%; specificity = 72.2%). When the cutoff was set to three events for the Cairo criteria, the diagnosis of SOS could be made 3 days earlier than that using the EBMT16 criteria, with comparable precision (specificity = 86.1%). The accuracy of the Cairo criteria improved further when the cutoff point was set to four (specificity = 93.8%). The fulfillment of the Cairo criteria was associated with high mortality. Based on our results, the Cairo criteria were also considered clinically useful, especially at three or four cutoff points. Further studies are required to validate and refine the criteria.

論文の公開元へ

この論文で使われている画像

参考文献

1. Yakushijin K, Atsuta Y, Doki N, Yokota A, Kanamori H, Miyamoto T,

et al. Sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation: incidence, risk factors and outcomes.

Bone Marrow Transplant. 2016;51(3):403–9. e-pub ahead of print

20151123; https://doi.org/10.1038/bmt.2015.283

2. Carreras E, Diaz-Beya M, Rosinol L, Martinez C, Fernandez-Aviles F,

Rovira M. The incidence of veno-occlusive disease following allogeneic

hematopoietic stem cell transplantation has diminished and the outcome improved over the last decade. Biol Blood Marrow Transplant.

26886146, 2023, 3, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/jha2.728 by Kobe University, Wiley Online Library on [21/08/2023]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License

703

ICHIKAWA ET AL .

10.

11.

12.

13.

14.

15.

ICHIKAWA ET AL .

2011;17(11):1713–20. e-pub ahead of print 20110625; https://doi.

org/10.1016/j.bbmt.2011.06.006

Coppell JA, Richardson PG, Soiffer R, Martin PL, Kernan NA, Chen A,

et al. Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome. Biol Blood Marrow Transplant. 2010;16(2):157–68. e-pub ahead of print 20090918; https://doi.

org/10.1016/j.bbmt.2009.08.024

Richardson PG, Smith AR, Triplett BM, Kernan NA, Grupp SA, Antin

JH, et al. Earlier defibrotide initiation post-diagnosis of veno-occlusive

disease/sinusoidal obstruction syndrome improves day +100 survival

following haematopoietic stem cell transplantation. Br J Haematol.

2017;178(1):112–8. e-pub ahead of print 20170426; https://doi.org/

10.1111/bjh.14727

Corbacioglu S, Greil J, Peters C, Wulffraat N, Laws HJ, Dilloo D,

et al. Defibrotide in the treatment of children with veno-occlusive

disease (VOD): a retrospective multicentre study demonstrates therapeutic efficacy upon early intervention. Bone Marrow Transplant.

2004;33(2):189–95. https://doi.org/10.1038/sj.bmt.1704329

Kernan NA, Grupp S, Smith AR, Arai S, Triplett B, Antin JH, et al.

Final results from a defibrotide treatment-IND study for patients with

hepatic veno-occlusive disease/sinusoidal obstruction syndrome. Br

J Haematol. 2018;181(6):816–27. e-pub ahead of print 20180516;

https://doi.org/10.1111/bjh.15267

McDonald GB, Hinds MS, Fisher LD, Schoch HG, Wolford JL, Banaji

M, et al. Veno-occlusive disease of the liver and multiorgan failure

after bone marrow transplantation: a cohort study of 355 patients.

Ann Intern Med. 1993;118(4):255–67. https://doi.org/10.7326/00034819-118-4-199302150-00003

Jones RJ, Lee KS, Beschorner WE, Vogel VG, Grochow LB, Braine

HG, et al. Venoocclusive disease of the liver following bone marrow

transplantation. Transplantation. 1987;44(6):778–83. https://doi.org/

10.1097/00007890-198712000-00011

Mohty M, Malard F, Abecassis M, Aerts E, Alaskar AS, Aljurf M,

et al. Revised diagnosis and severity criteria for sinusoidal obstruction

syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation.

Bone Marrow Transplant. 2016;51(7):906–12. e-pub ahead of print

20160516; https://doi.org/10.1038/bmt.2016.130

Cairo MS, Cooke KR, Lazarus HM, Chao N. Modified diagnostic criteria, grading classification and newly elucidated pathophysiology

of hepatic SOS/VOD after haematopoietic cell transplantation. Br

J Haematol. 2020;190(6):822–36. e-pub ahead of print 20200304;

https://doi.org/10.1111/bjh.16557

Stanworth SJ, Navarrete C, Estcourt L, Marsh J. Platelet

refractoriness–practical approaches and ongoing dilemmas in patient

management. Br J Haematol. 2015;171(3):297–305. e-pub ahead of

print 20150720; https://doi.org/10.1111/bjh.13597

Giralt S, Ballen K, Rizzo D, Bacigalupo A, Horowitz M, Pasquini M, et al.

Reduced-intensity conditioning regimen workshop: defining the dose

spectrum. Report of a workshop convened by the Center for International Blood and Marrow Transplant Research. Biol Blood Marrow

Transplant. 2009;15(3):367–9. https://doi.org/10.1016/j.bbmt.2008.

12.497

Trajman A, Luiz RR. McNemar chi2 test revisited: comparing sensitivity and specificity of diagnostic examinations. Scand J Clin Lab Invest.

2008;68(1):77–80. https://doi.org/10.1080/00365510701666031

Kanda Y. Investigation of the freely available easy-to-use

software ‘EZR’ for medical statistics. Bone Marrow Transplant. 2013;48(3):452–8. e-pub ahead of print 20121203;

https://doi.org/10.1038/bmt.2012.244

Richardson PG, Riches ML, Kernan NA, Brochstein JA, Mineishi S,

Termuhlen AM, et al. Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure. Blood.

2016;127(13):1656–65. e-pub ahead of print 20160129; https://doi.

org/10.1182/blood-2015-10-676924

16. Corbacioglu S, Carreras E, Ansari M, Balduzzi A, Cesaro S, Dalle

JH, et al. Diagnosis and severity criteria for sinusoidal obstruction

syndrome/veno-occlusive disease in pediatric patients: a new classification from the European Society for Blood and Marrow Transplantation. Bone Marrow Transplant. 2018;53(2):138–45. e-pub ahead of

print 20170731; https://doi.org/10.1038/bmt.2017.161

17. Kammersgaard MB, Kielsen K, Heilmann C, Ifversen M, Muller K.

Assessment of the proposed EBMT pediatric criteria for diagnosis

and severity grading of sinusoidal obstruction syndrome. Bone Marrow Transplant. 2019;54(9):1406–18. e-pub ahead of print 20190125;

https://doi.org/10.1038/s41409-018-0426-8

18. Ragoonanan D, Khazal SJ, Wang J, Payne A, Kohorst M, Harden A,

et al. Improved detection of sinusoidal obstructive syndrome using

pediatric-AYA diagnostic criteria and severity grading. Bone Marrow Transplant. 2021;56(1):175–84. e-pub ahead of print 20200714;

https://doi.org/10.1038/s41409-020-00998-w

19. Mohty M, Blaise D, Peffault de Latour R, Labopin M, Bourhis JH,

Bruno B, et al. Real-world use of defibrotide for veno-occlusive

disease/sinusoidal obstruction syndrome: the DEFIFrance Registry

Study. Bone Marrow Transplant. 2023;58(4):367–376. e-pub ahead of

print 20221223; https://doi.org/10.1038/s41409-022-01900-6

20. Rio B, Andreu G, Nicod A, Arrago JP, Dutrillaux F, Samama M, et al.

Thrombocytopenia in venocclusive disease after bone marrow transplantation or chemotherapy. Blood. 1986;67(6):1773–6. https://doi.

org/10.1182/blood.V67.6.1773.1773

21. Carreras E, Grañena A, Navasa M, Bruguera M, Marco V, Sierra J,

et al. On the reliability of clinical criteria for the diagnosis of hepatic

veno-occlusive disease. Ann Hematol. 1993;66(2):77–80. https://doi.

org/10.1007/bf01695888

22. Nishida M, Kahata K, Hayase E, Shigematsu A, Sato M, Kudo Y,

et al. Novel ultrasonographic scoring system of sinusoidal obstruction syndrome after hematopoietic stem cell transplantation. Biol

Blood Marrow Transplant. 2018;24(9):1896–900. e-pub ahead of print

20180524; https://doi.org/10.1016/j.bbmt.2018.05.025

23. Nishida M, Sugita J, Takahashi S, Iwai T, Sato M, Kudo Y, et al.

Refined ultrasonographic criteria for sinusoidal obstruction syndrome after hematopoietic stem cell transplantation. Int J Hematol.

2021;114(1):94–101. e-pub ahead of print 20210324; https://doi.org/

10.1007/s12185-021-03137-3

24. Corbacioglu S, Kernan NA, Pagliuca A, Ryan RJ, Tappe W, Richardson

PG. Incidence of anicteric veno-occlusive disease/sinusoidal obstruction syndrome and outcomes with defibrotide following hematopoietic cell transplantation in adult and pediatric patients. Biol Blood Marrow Transplant. 2020;26(7):1342–9. e-pub ahead of print 20200319;

https://doi.org/10.1016/j.bbmt.2020.03.011

SUPPORTING INFORMATION

Additional supporting information can be found online in the Supporting Information section at the end of this article.

How to cite this article: Ichikawa H, Yakushijin K, Miyata Y,

Kanehira H, Joyce M, Hirakawa Y, et al. Early diagnosis of

sinusoidal obstruction syndrome after hematopoietic stem cell

transplantation, with modified diagnostic criteria including

refractory thrombocytopenia. eJHaem. 2023;4:695–704.

https://doi.org/10.1002/jha2.728

704

...

参考文献をもっと見る

分野

大学

学位論文種類・取得年

言語

Early diagnosis of sinusoidal obstruction syndrome after hematopoietic stem cell transplantation, with modified diagnostic criteria including refractory thrombocytopenia

概要

この論文で使われている画像

関連論文

Efficacy of low-dose chemotherapy with methotrexate and vinblastine for patients with extra-abdominal desmoid-type fibromatosis: a systematic review

Machine Learning to Predict Three Types of Outcomes After Traumatic Brain Injury Using Data at Admission: A Multi-Center Study for Development and Validation

Utilizing machine learning for detecting patients with IgA nephropathy from computerized medical bill database

Applicability and eligibility of the International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) for patients who underwent revascularization with percutaneous coronary intervention (本文)

光力学診断補助下経尿道的膀胱腫瘍切除術(PDD-TURBT)の初期経験

参考文献

分野

大学

学位論文種類・取得年

言語

コピーが完了しました

URLをコピーしました

Early diagnosis of sinusoidal obstruction syndrome after hematopoietic stem cell transplantation, with modified diagnostic criteria including refractory thrombocytopenia

概要

この論文で使われている画像

関連論文

Efficacy of low-dose chemotherapy with methotrexate and vinblastine for patients with extra-abdominal desmoid-type fibromatosis: a systematic review

Machine Learning to Predict Three Types of Outcomes After Traumatic Brain Injury Using Data at Admission: A Multi-Center Study for Development and Validation

Utilizing machine learning for detecting patients with IgA nephropathy from computerized medical bill database

Applicability and eligibility of the International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) for patients who underwent revascularization with percutaneous coronary intervention (本文)

光力学診断補助下経尿道的膀胱腫瘍切除術(PDD-TURBT)の初期経験

参考文献